QMS Medical Allied Services Limited

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹109.81
Market cap
242 Cr
Stock P/E
20.3
P/B
2.33
Dividend yield
0.4%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Only consolidated filings are available for this company — standalone cannot be selected.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2025Dec 2025
Sales46 Cr37 Cr
Operating expenses (approx.)40 Cr30 Cr
EBITDA7 Cr7 Cr
OPM %14.5%18.9%
Other income0.32 Cr0.30 Cr
Interest1 Cr2 Cr
Depreciation0.86 Cr1 Cr
Profit before tax4 Cr4 Cr
Tax %29.6%25.8%
Net profit6 Cr3 Cr
EPS (₹)₹1.64₹1.24

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025Mar 2026TTM
Sales156 Cr173 CrSign in for TTM
Operating expenses (approx.)129 Cr146 CrSign in for TTM
EBITDA27 Cr27 CrSign in for TTM
OPM %17.4%15.6%Sign in for TTM
Other income2 Cr1 CrSign in for TTM
Interest5 Cr7 CrSign in for TTM
Depreciation4 Cr4 CrSign in for TTM
Profit before tax19 Cr16 CrSign in for TTM
Tax %26.6%27.5%Sign in for TTM
Net profit14 Cr12 CrSign in for TTM
EPS (₹)₹6.77₹5.40Sign in for TTM
Dividend payout %6.5%7.5%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025Mar 2026
Equity capital18 Cr19 Cr
Reserves72 Cr85 Cr
Borrowings
Other liabilities100 Cr109 Cr
Total liabilities190 Cr213 Cr
Fixed assets (net)23 Cr23 Cr
CWIP
Investments3 Cr5 Cr
Other assets120 Cr142 Cr
Total assets190 Cr213 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025Mar 2026
Cash from operating activity20 Cr19 Cr
Cash from investing-45 Cr-20 Cr
Cash from financing26 Cr1 Cr
Net cash flow0.52 Cr0.13 Cr
Free cash flow (OCF − Capex)20 Cr14 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025Mar 2026
ROCE %26.0%22.1%
ROE %15.3%11.4%
Debtor days101142
Inventory days9297
Days payable3939
Cash conversion cycle153200
Debt / equity0.0012
Current ratio1.641.56
Net debt / EBITDA-0.04-0.04